SEER*Rx Interactive Antineoplastic Drugs Database

A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Name	Category	Primary Site	Code?
131I-MIBG	Radiation		See Remarks
5-Aza-2'Deoxy-cytidine	Chemotherapy	CML	Yes
5-FP	Chemotherapy	Breast, gastric, head & neck, liver cancer	Yes
ABT 888	Chemotherapy	Ovary	Yes
ADXS-HPV	Biologic therapy (BRM, immunotherapy)	Cervix	Yes
AMG 531	Ancillary Agent		No
ATRA-IV	Differentiation inducing agent	Lymphoma, Acute promyelocytic leukemia	Yes
Abecma	Biologic therapy (BRM, immunotherapy)		Yes
Abemaciclib	Chemotherapy	Breast	Yes
Abiraterone acetate	Hormones and hormonal mechanisms	Prostate	Yes
Abraxane	Chemotherapy	Metastatic breast cancer, NSCLC, Non small cell lung cancer, cervix, melanoma, pancreas	Yes
Acalabrutinib	Chemotherapy		Yes
Accutane	Differentiation inducing agent	Prostate cancer	No
Acetaminophen	Ancillary Agent		No
Acetazolamide	Ancillary Agent		No
Acetylcysteine	Ancillary Agent	AIDS, Opportunistic infection	No
Acitretin	Differentiation inducing agent		No
Acyclovir	Ancillary Agent		No
Acyclovir Sodium	AIDS drug		No
Ad5CMV-p53 (adenovirus p53)	Biologic therapy (BRM, immunotherapy)	Glioma, Head & neck, lung cancer	No
Ado-trastuzumab emtansine	Biologic therapy (BRM, immunotherapy)	Metastatic HER-2 breast cancer	Yes
Adrenocorticotropic hormone	Hormones and hormonal mechanisms		See Remarks
Adstiladrin	Biologic therapy (BRM, immunotherapy)	bladder	Yes
Afinitor	Chemotherapy	breast, Lung, other cancer	Yes
Akeega	Chemotherapy	Prostate	See Remarks

Name	Primary Site
7+3
ABCD
ABCM
ABD
ABDIC
ABVD
AC	Breast
AC-T
ACOAP
ACOPP
ACT-FU-Cy
ACVBP
AD
ADE
ADM
ADOC
AIM
ALOMAD
APO regimen
ASHAP
ASHAP/M-BACOS
ATRA (263)
Adria-L-PAM
B-DOPA
BAC

Glossary